408 related articles for article (PubMed ID: 8763418)
1. An appraisal of acitretin therapy in children with inherited disorders of keratinization.
Lacour M; Mehta-Nikhar B; Atherton DJ; Harper JI
Br J Dermatol; 1996 Jun; 134(6):1023-9. PubMed ID: 8763418
[TBL] [Abstract][Full Text] [Related]
2. Clinical investigation of acitretin in children with severe inherited keratinization disorders in China.
Zhang XB; Luo Q; Li CX; He YQ; Xu X
J Dermatolog Treat; 2008; 19(4):221-8. PubMed ID: 18608715
[TBL] [Abstract][Full Text] [Related]
3. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
Katugampola RP; Finlay AY
Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
[TBL] [Abstract][Full Text] [Related]
4. Oral acitretin treatment in severe congenital ichthyosis of the neonate.
Saraçoğlu ZN; Tekin N; Urer SM; Sabuncu I; Akşit A
Turk J Pediatr; 2002; 44(1):61-4. PubMed ID: 11858383
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characterization and response to acitretin in three families with Sjögren-Larsson syndrome.
Vural S; Vural A; Akçimen F; Bağci IS; Tunca C; Gündoğdu Eken A; Ruzicka T; Başak AN
Int J Dermatol; 2018 Jul; 57(7):843-848. PubMed ID: 29704247
[TBL] [Abstract][Full Text] [Related]
6. Severe ichthyosis-related disorders in children: response to acitretin.
Zhang X; He Y; Zhou H; Luo Q; Li C
J Dermatolog Treat; 2007; 18(2):118-22. PubMed ID: 17520471
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and efficacy of continuous acitretin monotherapy for three children with different severe hyperkeratotic disorders in China.
Liang J; Chen P; Chen H; Tian X; Wu Z; Zhang S; Li C; Zhang X
J Dermatol; 2018 Aug; 45(8):1003-1008. PubMed ID: 29756235
[TBL] [Abstract][Full Text] [Related]
8. Retinoids in disorders of keratinization: their use in adults.
Happle R; van de Kerkhof PC; Traupe H
Dermatologica; 1987; 175 Suppl 1():107-24. PubMed ID: 2961628
[TBL] [Abstract][Full Text] [Related]
9. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study.
Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM
Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800
[TBL] [Abstract][Full Text] [Related]
10. Acitretin in the symptomatic therapy for severe recessive x-linked ichthyosis.
Bruckner-Tuderman L; Sigg C; Geiger JM; Gilardi S
Arch Dermatol; 1988 Apr; 124(4):529-32. PubMed ID: 2965549
[TBL] [Abstract][Full Text] [Related]
11. Long-term oral treatment of two pronounced ichthyotic conditions: lamellar ichthyosis and epidermolytic hyperkeratosis with the aromatic retinoid, Tigason (RO 10-9359).
El-Ramly M; Zachariae H
Acta Derm Venereol; 1983; 63(5):452-6. PubMed ID: 6197852
[TBL] [Abstract][Full Text] [Related]
12. Acitretin.
Ortiz NE; Nijhawan RI; Weinberg JM
Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
[TBL] [Abstract][Full Text] [Related]
13. Twenty-one years of oral retinoid therapy in siblings with nonbullous ichthyosiform erythroderma.
Macbeth AE; Johnston GA
Clin Exp Dermatol; 2008 Mar; 33(2):190-1. PubMed ID: 17927786
[No Abstract] [Full Text] [Related]
14. Etretinate may work where acitretin fails.
Bleiker TO; Bourke JF; Graham-Brown RA; Hutchinson PE
Br J Dermatol; 1997 Mar; 136(3):368-70. PubMed ID: 9115918
[TBL] [Abstract][Full Text] [Related]
15. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
Halverstam CP; Zeichner J; Lebwohl M
J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
[TBL] [Abstract][Full Text] [Related]
16. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
[TBL] [Abstract][Full Text] [Related]
17. Effects of acitretin on the liver.
Roenigk HH; Callen JP; Guzzo CA; Katz HI; Lowe N; Madison K; Nigra T; Fiedler VC; Armstrong RB
J Am Acad Dermatol; 1999 Oct; 41(4):584-8. PubMed ID: 10495381
[TBL] [Abstract][Full Text] [Related]
18. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
[TBL] [Abstract][Full Text] [Related]
19. Ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome treated with acitretin.
Khandpur S; Bhat R; Ramam M
J Eur Acad Dermatol Venereol; 2005 Nov; 19(6):759-62. PubMed ID: 16268889
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma.
Haftek M; Cambazard F; Dhouailly D; Réano A; Simon M; Lachaux A; Serre G; Claudy A; Schmitt D
Br J Dermatol; 1996 Sep; 135(3):448-53. PubMed ID: 8949442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
